Abstract S5-5: Trastuzumab plus adjuvant chemotherapy for HER2-positive breast cancer: Final planned joint analysis of overall survival (OS) from NSABP B-31 and NCCTG N9831
Year: 2012
Type: conference-abstract
Source: Cancer Research
Institutions: MedStar Washington Hospital Center, National Institutes of Health, Mayo Clinic, Memorial Sloan Kettering Cancer Center, University of Kentucky, University of Pittsburgh, University of Washington, Aultman Hospital, Allegheny General Hospital, Angeles Clinic and Research Institute, Dana-Farber Cancer Institute, UPMC Hillman Cancer Center, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, The University of Texas Southwestern Medical Center
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1997127252
